Researcher

Kong-Peng Lam obtained his PhD in Immunology from the College of Physicians & Surgeons at Columbia University, US. He then carried out postdoctoral research at the Institute for Genetics, University of Cologne, Germany, working to understand B cell biology and development. He is currently the Executive Director of the A*STAR Singapore Immunology Network (A*STAR SIgN); a Professor in the Departments of Microbiology and Immunology, Physiology, and Pediatrics at Yong Loo Lin School of Medicine, National University of Singapore; and an Adjunct Professor in the School of Biological Sciences at Nanyang Technological University, Singapore.
Related Articles
Taming T cells to douse eczema’s flare
22 Nov 2024A*STAR researchers discovered a potential new treatment for severe eczema by targeting a protein that
Blueprints to optimise a cancer killer
20 Dec 2023A*STAR researchers tackle the challenge of creating therapeutic antibodies that effectively kill tumours and are
Extinguishing the flames of inflammation
12 May 2023Researchers unravel a complex inflammatory pathway involved in severe COVID-19 infection and identify a therapeutic
mRNA boosters: our best bet against Omicron?
12 Apr 2023Booster shots with COVID-19 mRNA outperformed inactivated virus by eliciting stronger antibody responses to the
Tiny packages bring (cytokine) storm relief
16 Feb 2023A*STAR scientists decipher how a stem cell-based treatment stops the uncontrolled inflammation associated with severe
Making the most of natural cancer killers
30 Nov 2022A*STAR researchers discover a mechanism that fires up the metabolism of cancer-killing immune cells, paving